Objectives: To determine the average cost of a case of genital warts, for both males and
females, with a view to informing the current debate as to which Human papillomavirus …

Objective. To asses the burden and correlates of genital warts in women. Methods. We
conducted a population-based cross-sectional study in 69,147 women (18–45 years of age) …

Background Human papillomavirus (HPV) is a necessary cause of cervical cancer. HPV is
also responsible for benign condylomata acuminata, also known as genital warts. We …

Background Increasing evidence suggests that 1-dose human papillomavirus (HPV)
vaccination may protect significantly against HPV-related disease. We provide nationwide …

Background Shortly after the human papillomavirus (HPV) vaccine recommendation and
hence the reimbursement of vaccination costs for the respective age groups in Germany in …

Methods During 6 month (February 2010-July 2010) 20 private gynaecological centers in all
Czech Republic were counting up the number of genital warts cases. Risk factors, therapy …

HPV vaccination coverage rates can vary depending on several factors. The main objective
of this study is to identify possible independent prognostic factors that have an impact on …

We examined the effectiveness of human papillomavirus vaccination by dose number and
spacing against incident genital warts in a cohort of 64,517 female health-plan enrollees in …

Objectives To estimate the prevalence of, and describe risk factors for, genital warts (GWs) in
the British population, following the introduction of the bivalent (human papillomavirus (HPV) …

Human Papilloma Virus (HPV) infection and HPV-related cancers can be prevented through
vaccinations and mass cervical screening programmes. The Ministry of Health in Italy …